HIGHLIGHTS
- who: Rome Buathong and colleagues from the Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand have published the Article: Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants, in the Journal: Vaccines 2022, 1321 of /2022/
- how: Ultimately in this study the data show that the use of the BNT162b2 as both first and second booster generated the strongest responses against all strain and variants. The data generated in this study were based on an in_vitro . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.